Stephen B. Thacker CDC Library collection

Search Results

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

All Collections

Morbidity and Mortality Weekly Report (MMWR)

The Morbidity and Mortality Weekly Report (MMWR) series is CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements.

Narrow Results:

North America 81

61 - 80 of 8391 Results

Refine Results:

Previous 1 ... 3 4 5 ... 420

Recommendations for preventing transmission of infections among chronic hemodialysis patients

CITE Title : Recommendations for preventing transmission of infections among chronic hemodialysis patients Personal Author(s) : Alter, Miriam J.;Arduino, Matthew J.;Lyerla, Harold Craig;Miller, Elaine R.;Tokars, Jerome I.; Corporate Authors(s) : National Center for Infectious Diseases (U.S.);Centers for Disease Control and Prevention (U.S.);National Center for Infectious Diseases (U.S.). Hospital Infections Program;National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases; Published Date : April 27, 2001 Series : MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 50, no. RR-5 URL : https://stacks.cdc.gov/view/cdc/13528 Alter, Miriam J. et al. (2001). Recommendations for preventing transmission of infections among chronic hemodialysis patients. Alter, Miriam J. et al. "Recommendations for preventing transmission of infections among chronic hemodialysis patients" (2001) Alter, Miriam J. et al. "Recommendations for preventing transmission of infections among chronic hemodialysis patients" , 2001 Export RIS Citation Information.

[PDF - 386.09 KB]

Personal Author:

Alter, Miriam J. ;

Arduino, Matthew J.
...

April 27, 2001 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 50, no. RR-5

Description:

These recommendations replace previous recommendations for the prevention of bloodborne virus infections in hemodialysis centers and provide additiona...

Status:

current

File Type:

[PDF - 386.09 KB]

File Type:

[PDF - 386.09 KB]
Transmission of SARS-COV-2 infections in households — Tennessee and Wisconsin, April–September 2020

CITE Title : Transmission of SARS-COV-2 infections in households — Tennessee and Wisconsin, April–September 2020 Personal Author(s) : Grijalva, Carlos G.;Rolfes, Melissa A.;Zhu, Yuwei;McLean, Huong Q.;Hanson, Kayla E.;Belongia, Edward A.;Halasa, Natasha B.;Kim, Ahra;Reed, Carrie;Fry, Alicia M.;Talbot, H. Keipp; Corporate Authors(s) : Vanderbilt University Medical Center.;CDC COVID-19 Response Team.;Marshfield Clinic Research Institute.; Published Date : October 30, 2020 URL : https://stacks.cdc.gov/view/cdc/96340 Grijalva, Carlos G. et al. (2020). Transmission of SARS-COV-2 infections in households — Tennessee and Wisconsin, April–September 2020. Grijalva, Carlos G. et al. "Transmission of SARS-COV-2 infections in households — Tennessee and Wisconsin, April–September 2020" (2020) Grijalva, Carlos G. et al. "Transmission of SARS-COV-2 infections in households — Tennessee and Wisconsin, April–September 2020" , 2020 Export RIS Citation Information.

[PDF - 152.50 KB]

Personal Author:

Grijalva, Carlos G. ;

Rolfes, Melissa A.
...

October 30, 2020

Description:

What is already known about this topic? Transmission of SARS-CoV-2 occurs within households; however, Transmission estimates vary widely and the data ...

File Type:

[PDF - 152.50 KB]

File Type:

[PDF - 152.50 KB]
Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — SET-NET, 16 jurisdictions, March 29–October 14, 2020

CITE Title : Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — SET-NET, 16 jurisdictions, March 29–October 14, 2020 Personal Author(s) : Woodworth, Kate R.;Olsen, Emily O’Malley;Neelam, Varsha;Lewis, Elizabeth L.;Galang, Romeo R.;Oduyebo, Titilope;Aveni, Kathryn;Yazdy, Mahsa M.;Harvey, Elizabeth;Longcore, Nicole D.;Barton, Jerusha;Fussman, Chris;Siebman, Samantha;Lush, Mamie;Patrick, Paul H.;Halai, Umme-Aiman;Valencia-Prado, Miguel;Orkis, Lauren;Sowunmi, Similoluwa;Schlosser, Levi;Khuwaja, Salma;Read, Jennifer S.;Hall, Aron J.;Meaney-Delman, Dana;Ellington, Sascha R.;Gilboa, Suzanne M.;Tong, Van T.; Corporate Authors(s) : New Jersey. Department of Health.;Massachusetts. Department of Public Health.;Tennessee. Department of Health.;New York (State). Department of Health. Georgia. Department of Public Healt;Michigan. Department of Health and Human Service;Minnesota. Department of Health.;Nebraska. Department of Health and Human Service.;Oklahoma. State Department of Health.;Los Angeles County (Calif.). Department of Public Health.;Puerto Rico. Department of Health.;Pennsylvania. Department of Health.;California. Department of Public Health.;North Dakota. Department of Health.;Houston (Tex.). Health Department.;Vermont. Department of Health.; Published Date : November 2, 2020 URL : https://stacks.cdc.gov/view/cdc/96342 Woodworth, Kate R. et al. (2020). Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — SET-NET, 16 jurisdictions, March 29–October 14, 2020. Woodworth, Kate R. et al. "Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — SET-NET, 16 jurisdictions, March 29–October 14, 2020" (2020) Woodworth, Kate R. et al. "Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — SET-NET, 16 jurisdictions, March 29–October 14, 2020" , 2020 Export RIS Citation Information.

[PDF - 148.65 KB]

Personal Author:

Woodworth, Kate R. ;

Olsen, Emily O’Malley
...

November 2, 2020

Description:

What is already known about this topic? Pregnant women with SARS-CoV-2 infection are at increased risk for severe illness compared with nonpregnant wo...

File Type:

[PDF - 148.65 KB]

File Type:

[PDF - 148.65 KB]
Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020

CITE Title : Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020 Personal Author(s) : Zambrano, Laura D.;Ellington, Sascha;Strid, Penelope;Galang, Romeo R.;Oduyebo, Titilope;Tong, Van T.;Woodworth, Kate R.;Nahabedian John F.;Azziz-Baumgartner, Eduardo;Gilboa, Suzanne M.;Meaney-Delman, Dana; Corporate Authors(s) : CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team.;CDC COVID-9 Response Team.; Published Date : November 2, 2020 URL : https://stacks.cdc.gov/view/cdc/96341 Zambrano, Laura D. et al. (2020). Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020. Zambrano, Laura D. et al. "Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020" (2020) Zambrano, Laura D. et al. "Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020" , 2020 Export RIS Citation Information.

[PDF - 246.91 KB]

Personal Author:

Zambrano, Laura D. ;

Ellington, Sascha
...

November 2, 2020

Description:

What is already known about this topic? Limited information suggests that pregnant women with COVID-19 might be at increased risk for severe illness c...

File Type:

[PDF - 246.91 KB]

File Type:

[PDF - 246.91 KB]
SUPPLEMENTARY BOX 2. Sexual behavior and transmission parameters used in “Modeling the impact of sexual networks in the transmission of Monkeypox virus between gay, bisexual, and other men who have sex with men”

CITE Title : SUPPLEMENTARY BOX 2. Sexual behavior and transmission parameters used in “Modeling the impact of sexual networks in the transmission of Monkeypox virus between gay, bisexual, and other men who have sex with men” Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : September 2, 2022 Source : Spicknall IH, Pollock ED, Clay PA, et al. Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex With Men — United States, 2022. MMWR Morb Mortal Wkly Rep. ePub: 26 August 2022. URL : https://stacks.cdc.gov/view/cdc/120606 Centers for Disease Control and Prevention (U.S.) (2022). SUPPLEMENTARY BOX 2. Sexual behavior and transmission parameters used in “Modeling the impact of sexual networks in the transmission of Monkeypox virus between gay, bisexual, and other men who have sex with men”. Centers for Disease Control and Prevention (U.S.) "SUPPLEMENTARY BOX 2. Sexual behavior and transmission parameters used in “Modeling the impact of sexual networks in the transmission of Monkeypox virus between gay, bisexual, and other men who have sex with men”" (2022) Centers for Disease Control and Prevention (U.S.) "SUPPLEMENTARY BOX 2. Sexual behavior and transmission parameters used in “Modeling the impact of sexual networks in the transmission of Monkeypox virus between gay, bisexual, and other men who have sex with men”" , 2022 Export RIS Citation Information.

[PDF - 153.89 KB]

:

Centers for Disease Control and Prevention (U.S.)

September 2, 2022 | Spicknall IH, Pollock ED, Clay PA, et al. Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex With Men — United States, 2022. MMWR Morb Mortal Wkly Rep. ePub: 26 August 2022.

No Description

File Type:

[PDF - 153.89 KB]

File Type:

[PDF - 153.89 KB]
SUPPLEMENTARY BOX 1. Simulation Design and sexual behavior data

CITE Title : SUPPLEMENTARY BOX 1. Simulation Design and sexual behavior data Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : September 2, 2022 Source : Spicknall IH, Pollock ED, Clay PA, et al. Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex With Men — United States, 2022. MMWR Morb Mortal Wkly Rep. ePub: 26 August 2022. URL : https://stacks.cdc.gov/view/cdc/120605 Centers for Disease Control and Prevention (U.S.) (2022). SUPPLEMENTARY BOX 1. Simulation Design and sexual behavior data. Centers for Disease Control and Prevention (U.S.) "SUPPLEMENTARY BOX 1. Simulation Design and sexual behavior data" (2022) Centers for Disease Control and Prevention (U.S.) "SUPPLEMENTARY BOX 1. Simulation Design and sexual behavior data" , 2022 Export RIS Citation Information.

[PDF - 116.47 KB]

:

Centers for Disease Control and Prevention (U.S.)

September 2, 2022 | Spicknall IH, Pollock ED, Clay PA, et al. Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex With Men — United States, 2022. MMWR Morb Mortal Wkly Rep. ePub: 26 August 2022.

No Description

File Type:

[PDF - 116.47 KB]

File Type:

[PDF - 116.47 KB]
Vital Signs : Health Worker–Perceived Working Conditions and Symptoms of Poor Mental Health — Quality of Worklife Survey, United States, 2018–2022

CITE Title : Vital Signs : Health Worker–Perceived Working Conditions and Symptoms of Poor Mental Health — Quality of Worklife Survey, United States, 2018–2022 Personal Author(s) : Nigam, Jeannie A. S.;Barker, R. Michael;Cunningham, Thomas R.;Swanson, Naomi G.;L. Casey Chosewood,; Corporate Authors(s) : National Institute for Occupational Safety and Health. Published Date : October 24, 2023 Series : CDC Vital signs Source : MMWR. Morbidity and Mortality Weekly Report ; v. 72, early release, October 24, 2023 URL : https://stacks.cdc.gov/view/cdc/134794 Nigam, Jeannie A. S. et al. (2023). Vital Signs : Health Worker–Perceived Working Conditions and Symptoms of Poor Mental Health — Quality of Worklife Survey, United States, 2018–2022. Nigam, Jeannie A. S. et al. "Vital Signs : Health Worker–Perceived Working Conditions and Symptoms of Poor Mental Health — Quality of Worklife Survey, United States, 2018–2022" (2023) Nigam, Jeannie A. S. et al. "Vital Signs : Health Worker–Perceived Working Conditions and Symptoms of Poor Mental Health — Quality of Worklife Survey, United States, 2018–2022" , 2023 Export RIS Citation Information.

[PDF - 3.40 MB]

Personal Author:

Nigam, Jeannie A. S. ;

Barker, R. Michael
...

October 24, 2023 | CDC Vital signs

No Description

File Type:

[PDF - 3.40 MB]

File Type:

[PDF - 3.40 MB]
SUPPLEMENTARY TABLE 1. Vaccine effectiveness* of bivalent compared with effectiveness of original monovalent vaccination against COVID-19-related thromboembolic events† among Medicare beneficiaries aged ≥65 years with immunocompromise§ and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis¶ with immunocompromise, by age group and time since vaccination — United States, September 2022–March 2023

CITE Title : SUPPLEMENTARY TABLE 1. Vaccine effectiveness* of bivalent compared with effectiveness of original monovalent vaccination against COVID-19-related thromboembolic events† among Medicare beneficiaries aged ≥65 years with immunocompromise§ and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis¶ with immunocompromise, by age group and time since vaccination — United States, September 2022–March 2023 Published Date : January 11, 2024 Series : MMWR. Morbidity and Mortality Weekly Report ; v. 73, no. 1 URL : https://stacks.cdc.gov/view/cdc/140316 "SUPPLEMENTARY TABLE 1. Vaccine" (2024). "SUPPLEMENTARY TABLE 1. Vaccine effectiveness* of bivalent compared with effectiveness of original monovalent vaccination against COVID-19-related thromboembolic events† among Medicare beneficiaries aged ≥65 years with immunocompromise§ and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis¶ with immunocompromise, by age group and time since vaccination — United States, September 2022–March 2023" (2024) "SUPPLEMENTARY TABLE 1. Vaccine effectiveness* of bivalent compared with effectiveness of original monovalent vaccination against COVID-19-related thromboembolic events† among Medicare beneficiaries aged ≥65 years with immunocompromise§ and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis¶ with immunocompromise, by age group and time since vaccination — United States, September 2022–March 2023" , 2024 Export RIS Citation Information.

[PDF - 170.67 KB]

January 11, 2024 | MMWR. Morbidity and Mortality Weekly Report ; v. 73, no. 1

No Description

File Type:

[PDF - 170.67 KB]

File Type:

[PDF - 170.67 KB]
SUPPLEMENTARY TABLE 2. Vaccine effectiveness* of bivalent compared with effectiveness of original monovalent vaccination against all-cause thromboembolic events† among immunocompetent Medicare beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis§ without additional immunocompromising conditions, by age group and time since vaccination — United States, September 2022–March 2023

CITE Title : SUPPLEMENTARY TABLE 2. Vaccine effectiveness* of bivalent compared with effectiveness of original monovalent vaccination against all-cause thromboembolic events† among immunocompetent Medicare beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis§ without additional immunocompromising conditions, by age group and time since vaccination — United States, September 2022–March 2023 Published Date : January 11, 2024 Series : MMWR. Morbidity and Mortality Weekly Report ; v. 73, no. 1 URL : https://stacks.cdc.gov/view/cdc/140315 "SUPPLEMENTARY TABLE 2. Vaccine" (2024). "SUPPLEMENTARY TABLE 2. Vaccine effectiveness* of bivalent compared with effectiveness of original monovalent vaccination against all-cause thromboembolic events† among immunocompetent Medicare beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis§ without additional immunocompromising conditions, by age group and time since vaccination — United States, September 2022–March 2023" (2024) "SUPPLEMENTARY TABLE 2. Vaccine effectiveness* of bivalent compared with effectiveness of original monovalent vaccination against all-cause thromboembolic events† among immunocompetent Medicare beneficiaries aged ≥65 years and beneficiaries aged ≥18 years with end stage renal disease receiving dialysis§ without additional immunocompromising conditions, by age group and time since vaccination — United States, September 2022–March 2023" , 2024 Export RIS Citation Information.

[PDF - 166.48 KB]

January 11, 2024 | MMWR. Morbidity and Mortality Weekly Report ; v. 73, no. 1

No Description

File Type:

[PDF - 166.48 KB]

File Type:

[PDF - 166.48 KB]
Figure 3-3. Process for Classifying Cases of Hepatitis B as Acute and Chronic

CITE Title : Figure 3-3. Process for Classifying Cases of Hepatitis B as Acute and Chronic Published Date : January 18, 2024 URL : https://stacks.cdc.gov/view/cdc/145651 "Figure 3-3. Process for" (2024). "Figure 3-3. Process for Classifying Cases of Hepatitis B as Acute and Chronic" (2024) "Figure 3-3. Process for Classifying Cases of Hepatitis B as Acute and Chronic" , 2024 Export RIS Citation Information.

[PDF - 647.76 KB]

January 18, 2024

Description:

Flowchart demonstrating how to identify a patient with acute or chronic hepatitis B. This guide is intended to inform cases of hepatitis B.

File Type:

[PDF - 647.76 KB]

File Type:

[PDF - 647.76 KB]
Guidelines for Performing Single-Platform Absolute CD4+ T-cell Determinations with CD45 Gating for Persons Infected with Human Immunodeficiency Virus; and, Guidelines for Using the QuantiFERON-TB Test for Diagnosing Latent Mycobacterium Tuberculosis Infection

CITE Title : Guidelines for Performing Single-Platform Absolute CD4+ T-cell Determinations with CD45 Gating for Persons Infected with Human Immunodeficiency Virus; and, Guidelines for Using the QuantiFERON-TB Test for Diagnosing Latent Mycobacterium Tuberculosis Infection Personal Author(s) : Mazurek, Gerald H.;McDougal, J. Steven;Nicholson, Janet K. A., 1948-;Villarino, Margarita E.; Corporate Authors(s) : National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.;Centers for Disease Control and Preventiom (U.S.);National Center for Infectious Diseases (U.S.);National Center for Infectious Diseases (U.S.), Division of AIDS, STD, and TB Laboratory Research.; Published Date : January 31, 2003 Series : MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-2 URL : https://stacks.cdc.gov/view/cdc/6832 Mazurek, Gerald H. et al. (2003). Guidelines for Performing Single-Platform Absolute CD4+ T-cell Determinations with CD45 Gating for Persons Infected with Human Immunodeficiency Virus; and, Guidelines for Using the QuantiFERON-TB Test for Diagnosing Latent Mycobacterium Tuberculosis Infection. Mazurek, Gerald H. et al. "Guidelines for Performing Single-Platform Absolute CD4+ T-cell Determinations with CD45 Gating for Persons Infected with Human Immunodeficiency Virus; and, Guidelines for Using the QuantiFERON-TB Test for Diagnosing Latent Mycobacterium Tuberculosis Infection" (2003) Mazurek, Gerald H. et al. "Guidelines for Performing Single-Platform Absolute CD4+ T-cell Determinations with CD45 Gating for Persons Infected with Human Immunodeficiency Virus; and, Guidelines for Using the QuantiFERON-TB Test for Diagnosing Latent Mycobacterium Tuberculosis Infection" , 2003 Export RIS Citation Information.

[PDF - 397.77 KB]

Personal Author:

Mazurek, Gerald H. ;

McDougal, J. Steven
...

January 31, 2003 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-2

Description:

Summary of "Guidelines for Performing Single-Platform Absolute CD4+ T-cell Determinations with CD45 Gating for Persons Infected with Human Immunodefic...

File Type:

[PDF - 397.77 KB]

File Type:

[PDF - 397.77 KB]
Vital Signs : Missed Opportunities for Preventing Congenital Syphilis — United States, 2022

CITE Title : Vital Signs : Missed Opportunities for Preventing Congenital Syphilis — United States, 2022 Personal Author(s) : McDonald, Robert;O’Callaghan, Kevin;Torrone, Elizabeth;Barbee, Lindley;Grey, Jeremy;Jackson, David;Woodworth, Kate;Olsen, Emily;Ludovic, Jennifer;Mayes, Nikki;Chen, Sherry;Wingard, Rachel;Jones, Michelle Johnson;Drame, Fanta;Bachmann, Laura;Romaguera, Raul;Mena, Leandro; Corporate Authors(s) : National Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.;National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Birth Defects and Infant Disorders.;National Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.); Published Date : November 7, 2023 Series : CDC Vital signs Source : MMWR. Morbidity and Mortality Weekly Report ; v. 72, early release, November 7, 2023 URL : https://stacks.cdc.gov/view/cdc/135001 McDonald, Robert et al. (2023). Vital Signs : Missed Opportunities for Preventing Congenital Syphilis — United States, 2022. McDonald, Robert et al. "Vital Signs : Missed Opportunities for Preventing Congenital Syphilis — United States, 2022" (2023) McDonald, Robert et al. "Vital Signs : Missed Opportunities for Preventing Congenital Syphilis — United States, 2022" , 2023 Export RIS Citation Information.

[PDF - 2.52 MB]

Personal Author:

McDonald, Robert ;

O’Callaghan, Kevin
...

November 7, 2023 | CDC Vital signs

No Description

File Type:

[PDF - 2.52 MB]

File Type:

[PDF - 2.52 MB]
National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020

CITE Title : National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : January 25, 2024 Series : MMWR. Morbidity and mortality weekly report ; v. 73, suppl. 1 Source : MMWR Suppl. 2024 Jan 25;73(1) URL : https://stacks.cdc.gov/view/cdc/145980 Centers for Disease Control and Prevention (U.S.) (2024). National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020. Centers for Disease Control and Prevention (U.S.) "National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020" (2024) Centers for Disease Control and Prevention (U.S.) "National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020" , 2024 Export RIS Citation Information.

[PDF - 1.11 MB]

:

Centers for Disease Control and Prevention (U.S.)

January 25, 2024 | MMWR. Morbidity and mortality weekly report ; v. 73, suppl. 1

Description:

su7301-H.pdf

File Type:

[PDF - 1.11 MB]

File Type:

[PDF - 1.11 MB]
CDC Laboratory Recommendations for Syphilis Testing, United States, 2024

CITE Title : CDC Laboratory Recommendations for Syphilis Testing, United States, 2024 Personal Author(s) : Papp, John R.;Park, Ina U.;Fakile, Yetunde;Pereira, Lara;Pillay, Allan;Bolan, Gail A.; Corporate Authors(s) : National Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.;University of California San Francisco.;Task Force for Global Health.; Published Date : February 8, 2024 Series : MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 73, RR-01 Source : MMWR Recomm Rep. 2024 Feb 8;73(1):1-32. URL : https://stacks.cdc.gov/view/cdc/147800 Papp, John R. et al. (2024). CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. Papp, John R. et al. "CDC Laboratory Recommendations for Syphilis Testing, United States, 2024" (2024) Papp, John R. et al. "CDC Laboratory Recommendations for Syphilis Testing, United States, 2024" , 2024 Export RIS Citation Information.

[PDF - 1.04 MB]

Personal Author:

Papp, John R. ;

Park, Ina U.
...

February 8, 2024 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 73, RR-01

Description:

This report provides new CDC recommendations for tests that can support a diagnosis of syphilis, including serologic testing and methods for the ident...

File Type:

[PDF - 1.04 MB]

File Type:

[PDF - 1.04 MB]
Compendium of Animal Rabies Prevention and Control, 2006: National Association of State Public Health Veterinarians, Inc. (NASPHV)

CITE Title : Compendium of Animal Rabies Prevention and Control, 2006: National Association of State Public Health Veterinarians, Inc. (NASPHV) Corporate Authors(s) : National Association of State Public Health Veterinarians (U.S.);Centers for Disease Control and Prevention (U.S.);National Center for Infectious Diseases (U.S.); Published Date : April 14, 2006 Series : Morbidity and mortality weekly report. Recommendations and reports ; v. 55, no. RR-5;MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 54, no. RR-5; URL : https://stacks.cdc.gov/view/cdc/6708 National Association of State Public Health Veterinarians (U.S.) (2006). Compendium of Animal Rabies Prevention and Control, 2006: National Association of State Public Health Veterinarians, Inc. (NASPHV). National Association of State Public Health Veterinarians (U.S.) "Compendium of Animal Rabies Prevention and Control, 2006: National Association of State Public Health Veterinarians, Inc. (NASPHV)" (2006) National Association of State Public Health Veterinarians (U.S.) "Compendium of Animal Rabies Prevention and Control, 2006: National Association of State Public Health Veterinarians, Inc. (NASPHV)" , 2006 Export RIS Citation Information.

[PDF - 138.22 KB]

:

National Association of State Public Health Veterinarians (U.S.) ...

April 14, 2006 | Morbidity and mortality weekly report. Recommendations and reports ; v. 55, no. RR-5

Description:

Rabies is a fatal viral zoonosis and a serious public health problem. The recommendations in this compendium serve as the basis for animal rabies prev...

File Type:

[PDF - 138.22 KB]

File Type:

[PDF - 138.22 KB]
Compendium of Animal Rabies Prevention and Control, 2008: National Association of State Public Health Veterinarians, Inc.

CITE Title : Compendium of Animal Rabies Prevention and Control, 2008: National Association of State Public Health Veterinarians, Inc. Corporate Authors(s) : National Association of State Public Health Veterinarians (U.S.);Centers for Disease Control and Prevention (U.S.); Published Date : April 18, 2008 Series : MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 57, no. RR-2 URL : https://stacks.cdc.gov/view/cdc/6942 National Association of State Public Health Veterinarians (U.S.) (2008). Compendium of Animal Rabies Prevention and Control, 2008: National Association of State Public Health Veterinarians, Inc.. National Association of State Public Health Veterinarians (U.S.) "Compendium of Animal Rabies Prevention and Control, 2008: National Association of State Public Health Veterinarians, Inc." (2008) National Association of State Public Health Veterinarians (U.S.) "Compendium of Animal Rabies Prevention and Control, 2008: National Association of State Public Health Veterinarians, Inc." , 2008 Export RIS Citation Information.

[PDF - 198.03 KB]

:

National Association of State Public Health Veterinarians (U.S.) ...

April 18, 2008 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 57, no. RR-2

Description:

"The recommendations in this compendium serve as a basis for animal rabies-prevention and -control programs throughout the United States and facilitat...

File Type:

[PDF - 198.03 KB]

File Type:

[PDF - 198.03 KB]
Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023

CITE Title : Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023 Personal Author(s) : Clemens, Tessa;Moreland, Briana;Mack, Karin A.;Thomas, Karen;Bergen, Gwen;Lee, Robin; Corporate Authors(s) : National Center for Injury Prevention and Control (U.S.). Division of Injury Prevention. Published Date : May 14, 2024 Series : MMWR. Morbidity and Mortality Weekly Report ; v. 73, early release, May 14, 2024;Vital signs; URL : https://stacks.cdc.gov/view/cdc/156291 Clemens, Tessa et al. (2024). Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023. Clemens, Tessa et al. "Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023" (2024) Clemens, Tessa et al. "Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure — United States, 2019–2023" , 2024 Export RIS Citation Information.

[PDF - 3.57 MB]

Personal Author:

Clemens, Tessa ;

Moreland, Briana
...

May 14, 2024 | MMWR. Morbidity and Mortality Weekly Report ; v. 73, early release, May 14, 2024

Description:

What is already known about this topic? Approximately 4,000 unintentional drowning deaths occur annually in the United States, and demographic dispari...

File Type:

[PDF - 3.57 MB]

File Type:

[PDF - 3.57 MB]
Supplementary Appendix. U.S. Selected Practice Recommendations for Contraceptive Use, 2024

CITE Title : Supplementary Appendix. U.S. Selected Practice Recommendations for Contraceptive Use, 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 01/01/2099 Series : MMWR Supplements URL : https://stacks.cdc.gov/view/cdc/156517 Centers for Disease Control and Prevention (U.S.) (2099). Supplementary Appendix. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. Centers for Disease Control and Prevention (U.S.) "Supplementary Appendix. U.S. Selected Practice Recommendations for Contraceptive Use, 2024" (2099) Centers for Disease Control and Prevention (U.S.) "Supplementary Appendix. U.S. Selected Practice Recommendations for Contraceptive Use, 2024" , 2099 Export RIS Citation Information.

[PDF - 1.19 MB]

:

Centers for Disease Control and Prevention (U.S.)

01/01/2099 | MMWR Supplements

No Description

Public Access Available on:

January 01, 2099

File Type:

[PDF - 1.19 MB]
Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024

CITE Title : Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 01/01/2099 Series : MMWR Supplements URL : https://stacks.cdc.gov/view/cdc/156516 Centers for Disease Control and Prevention (U.S.) (2099). Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Centers for Disease Control and Prevention (U.S.) "Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024" (2099) Centers for Disease Control and Prevention (U.S.) "Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024" , 2099 Export RIS Citation Information.

[PDF - 651.01 KB]

:

Centers for Disease Control and Prevention (U.S.)

01/01/2099 | MMWR Supplements

No Description

Public Access Available on:

January 01, 2099

File Type:

[PDF - 651.01 KB]
SUPPLEMENTAL TABLE 1. Annual counts and age-adjusted incidence rates* of confirmed coccidioidomycosis cases, statewide and by region of residence†, 2000–2018 (n = 65,438)

CITE Title : SUPPLEMENTAL TABLE 1. Annual counts and age-adjusted incidence rates* of confirmed coccidioidomycosis cases, statewide and by region of residence†, 2000–2018 (n = 65,438) Published Date : December 4, 2020 Series : MMWR. Morbidity and Mortality Weekly Report ; v. 69, no. 48, p. URL : https://stacks.cdc.gov/view/cdc/97708 "SUPPLEMENTAL TABLE 1. Annual" (2020). (48). "SUPPLEMENTAL TABLE 1. Annual counts and age-adjusted incidence rates* of confirmed coccidioidomycosis cases, statewide and by region of residence†, 2000–2018 (n = 65,438)" , no. 48 (2020) "SUPPLEMENTAL TABLE 1. Annual counts and age-adjusted incidence rates* of confirmed coccidioidomycosis cases, statewide and by region of residence†, 2000–2018 (n = 65,438)" , no. 48, 2020 Export RIS Citation Information.

[PDF - 111.30 KB]

December 4, 2020 | MMWR. Morbidity and Mortality Weekly Report ; v. 69, no. 48, p.

Description:

Supplementary table for: Regional Analysis of coccidioidomycosis incidence — California, 2000–2018.

File Type:

[PDF - 111.30 KB]

File Type:

[PDF - 111.30 KB]

61 - 80 / 8391

Previous 1 ... 3 4 5 ... 420